Navigation Links
Fish Oil Seems to Help Cancer Patients Preserve Muscle

MONDAY, Feb. 28 (HealthDay News) -- Cancer patients undergoing chemotherapy may be able to avoid the accompanying muscle loss and malnutrition by taking fish oil supplements that contain omega-3 fatty acids, new research suggests.

The finding is based on a small study involving just 40 lung cancer patients. Nevertheless, it raises hope that a simple, noninvasive intervention might go a long way towards countering the fatigue, poorer prognosis and impaired quality of life that can result from chemo-induced muscle mass loss.

"Fish oil may prevent loss of weight and muscle by interfering with some of the pathways that are altered in advanced cancer," study author Dr. Vera Mazurak, of the University of Alberta in Edmonton, Canada, said in a news release. "This holds great promise, because currently there is no effective treatment for cancer-related malnutrition."

Mazurak and her colleagues report their observations in the Feb. 28 online edition of Cancer.

To explore the therapeutic potential of fish oil supplements, the authors offered 16 cancer patients undergoing an initial 10-week chemotherapy regimen a daily dose of 2.2 grams of a particular omega-3 fatty acid called eicosapentaenoic (EPA).

While these patients took fish oil supplements throughout their chemotherapy treatment, a second group of 24 patients underwent the same regimen minus the fish oil.

The results: continual muscle and fat measurements revealed that the group that took no fish oil supplementation lost an average of just over 5 pounds; the supplement group lost no weight.

What's more, blood analyses revealed that those in the fish oil group who had the biggest bump in bloodstream EPA concentrations also had the greatest muscle mass gains.

Specifically, nearly 70 percent of those in the fish oil group either kept their pre-chemo muscle mass or gained muscle. By comparison, less than 30 percent in the non-supplement group kept their original muscle mass.

Total fat tissue measurements were unaffected by fish oil supplementation, the team noted, and no side effects were observed.

The authors concluded that fish oil supplementation appears to be a safe and effective way to prevent malnutrition among cancer patients, and may ultimately prove to be of benefit for other groups of people, such as elderly patients who also face a significant ongoing risk for muscle loss.

Lona Sandon, a registered dietitian and assistant professor of clinical nutrition at the University of Texas Southwestern Dallas, reacted with cautious optimism to the findings.

"Malnutrition is a big concern with cancer patients undergoing chemotherapy and radiation," she noted. "Because first of all they do have wasting from the cancer itself, which is very metabolically active and eats up your energy stores. And then with chemotherapy, there is some inflammation that's detrimental to the heart and muscle, as it can cause muscle breakdown. And preservation of lean muscle tissue, we know, leads to better outcomes."

"So certainly this does seem to be promising," Sandon said. "And other similar studies have looked at omega-3 and muscle preservation and have also suggested that fish oil can act to prevent inflammation caused by both disease and hardcore medications, like chemotherapy agents."

"But I would caution that the amount of pure concentrated fish oil supplement the people in this study were given is a lot," she added. "Much much more than any recommended dietary allowance, along the lines of two to three servings of fish per week."

But, she said, "I would say this is certainly worthy of continuing research and exploration. But meanwhile, people should definitely not go out and start consuming huge amounts of fish oil."

More information

For more on chemotherapy, visit the American Cancer Society.

--Alan Mozes

SOURCE: Cancer, Feb. 28, 2011, news release; Lona Sandon, dietitian and assistant professor, clinical nutrition, University of Texas Southwestern, Dallas

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Bilingualism Seems to Boost Brain Power
2. Obesity Seems to Cut Womens Risk of Open-Angle Glaucoma
3. Better Nutrition Seems to Help Preemies With Lung Disease
4. With Cataracts, Misinformation Seems to Abound
5. Positive Mood Seems to Boost Creativity
6. Weight Gain Seems to Change the Brains Response to Food
7. Depression With Psychotic-Like Symptoms Seems Tougher to Treat
8. Race Seems to Impact Rate of Kidney Function Decline
9. Early Intro to Math Seems to Improve Kids Skills Later
10. Activity Level Seems to Decline Throughout College Years
11. Plantar fasciitis? Stretching seems to do the trick
Post Your Comments:
Related Image:
Fish Oil Seems to Help Cancer Patients Preserve Muscle
(Date:11/30/2015)... ... November 30, 2015 , ... ... of the leading plastic surgery practices in Florida, is proud to announce that ... for surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon ...
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... (AIS) is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three ... learned from three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint ...
(Date:11/30/2015)... ... , ... Sikka Software announced today that they are showcasing the Sikka Software ... complex business decisions by providing the tools and information they need to grow their ... procedures customized by zip code. , The Sikka Software Ecosystem includes over 32 ...
(Date:11/30/2015)... ... November 30, 2015 , ... The successful filing of an Investigational ... it is so important to this key industry segment, Regis Technologies has decided to ... on December 4th at 11am EST. , Federal law does not allow new drugs ...
(Date:11/30/2015)... EMIGSVILLE, PA (PRWEB) , ... November 30, 2015 ... ... (CCMS) software provider, has verified that their Vasont Universal Integrator (VUI) extension unites ... handle creating, editing, and managing content as a continuous process with the latest ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)...  Hanger, Inc. (NYSE: HGR ) (the "Company") ... of its previously announced consent solicitation (as amended and ... principal amount 7⅛% Senior Notes due 2018 (the "Notes") ... payable pursuant to the Consent Solicitation, (ii) the proposed ... expiration date of the Consent Solicitation.    ...
(Date:11/30/2015)... 2015  Novartis will demonstrate the strength of its ... American Society of Hematology (ASH) Annual Meeting. Presentations will ... as supportive care, including key findings in rare and ... The ASH Annual Meeting will be held December 5-8 ... Novartis Oncology . "We will be presenting encouraging overall ...
(Date:11/30/2015)... , Nov. 30, 2015   VolitionRx Limited (NYSE ... diagnostic tests for a broad range of cancer types and ... LD Micro Conference, which will be held December 1 - 3 ... from VolitionRx will be David Kratochvil , Chief Financial ... of Investor Relations. ® blood-based tests for ...
Breaking Medicine Technology: